1wok
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /> <applet load="1wok" size="450" color="white" frame="true" align="right" spinBox="true" caption="1wok, resolution 3.00Å" /> '''Crystal structure o...)
Next diff →
Revision as of 17:46, 12 November 2007
|
Crystal structure of catalytic domain of human poly(ADP-ribose) polymerase complexed with a quinoxaline-type inhibitor
Contents |
Overview
Two classes of quinazolinone derivatives and quinoxaline derivatives were, identified as potent and selective poly(ADP-ribose) polymerase-1 and 2, (PARP-1) and (PARP-2) inhibitors, respectively. In PARP enzyme assays, using recombinant PARP-1 and PARP-2, quinazolinone derivatives displayed, relatively high selectivity for PARP-1 and quinoxaline derivatives showed, superior selectivity for PARP-2. SBDD analysis via a combination of X-ray, structural study and homology modeling suggested distinct interactions of, inhibitors with PARP-1 and PARP-2. These findings provide a new structural, framework for the design of selective inhibitors for PARP-1 and PARP-2.
Disease
Known diseases associated with this structure: Xeroderma pigmentosum (1) OMIM:[173870]
About this Structure
1WOK is a Single protein structure of sequence from Homo sapiens with CNQ as ligand. Active as NAD(+) ADP-ribosyltransferase, with EC number 2.4.2.30 Full crystallographic information is available from OCA.
Reference
Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors., Iwashita A, Hattori K, Yamamoto H, Ishida J, Kido Y, Kamijo K, Murano K, Miyake H, Kinoshita T, Warizaya M, Ohkubo M, Matsuoka N, Mutoh S, FEBS Lett. 2005 Feb 28;579(6):1389-93. PMID:15733846
Page seeded by OCA on Mon Nov 12 19:53:05 2007
